Versant Capital Management, Inc Olema Pharmaceuticals, Inc. Transaction History
Versant Capital Management, Inc
- $578 Million
- Q1 2025
A detailed history of Versant Capital Management, Inc transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,603 shares of OLMA stock, worth $7,822. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,603
Previous 643
149.3%
Holding current value
$7,822
Previous $3,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding OLMA
# of Institutions
159Shares Held
67.7MCall Options Held
235KPut Options Held
1.3K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$36.5 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$35.6 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$27.9 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$19.5 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$17.9 Million0.05% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $197M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...